AstaREAL® Seminar at NPEA Hong Kong - Fri. Aug, 27th 11:30-12:15 Venue: Show Floor
AstaREAL Quench the 10 Factors that Kill 1 Boomer every 2 Second
SEMINAR – Fri. Aug, 27th 11:30-12:15
Venue: Show Floor
AstaREAL and THE 10 FACTORS
- Increase HDL Cholesterol
- Reduce lipid Peroxidation
- Reduce triglycerides
- Reduce macrophage inflammatory responses
- Reduce plaque formation
- Improve vascular tone
- Increase plaque stability
- Reduce blood pressure
- Reduce plaque rupture
- Improve blood flow
AstaREAL adds cutting-edge value to anti-aging products, satisfying a wider range of customers’ needs with different lifestyle, cardiovascular conditions and age groups.
AstaREAL® Astaxanthin Reduces Wrinkles and Age Spots
Ignoring Women's Feelings Put Brands on their Black Lists in Skin Care Products AstaREAL® Astaxanthin can Increase Brand Loyalty for Skin Care Products because it fulfills women expectations and provide positive emotions that are rooted in visible improvements of their wrinkles and dry skin condition
Water Soluble Astaxanthin for Ready-to-drink functional Beverages
BURLINGTON, N.J.—Fuji Health Science, Inc. introduced AstaREAL Clear 75, a water-soluble natural astaxanthin designed for ready-to-drink functional beverages for both the food and dietary-supplement industries. Astaxanthin is a GRAS ingredient.
Yasuko Kuroda, Vice President of Fuji Health Science said, "These two milestones clearly provide the market with the opportunity of expanding the use of astaxanthin into both the food industry as well as the untapped beverage market segment. To achieve this we will be introducing AstaREAL Clear 75 to the food industry at the IFT in July"
AstaREAL Clear 75 joins Fuji's other functional forms of natural astaxanthin: AstaREAL L10, a CO2, solvent free extract of Haematococcus pluvialis and AstaREAL P2AF, a cold water dispersible and directly compressible powdered astaxanthin extract suitable for powdered drinks, two piece capsules and tablets.
Kuroda added, "To work with Clear 75 is truly amazing. It mixes with any aqueous system instantly and remains completely clear with no separation or residual film. This is a must to work with."
AstaREAL astaxanthin is a member of the carotenoid family of natural pigments closely related to beta carotene, lycopene and lutein. It is a powerful natural biological antioxidant known for its ability to better protect against singlet oxygen, the most damaging of all reactive oxygen species (ROS), than any other known antioxidant. It is also what gives the pink and orange color to salmon, shrimp and lobster. The most abundant source of natural astaxanthin can be found in the fresh water microalgae Haematococcus pluvialis. To provide a supply of natural astaxanthin to consumers throughout the world and to ensure maximum purity Fuji cultivates AstaREAL astaxanthin in fully enclosed state of the art bio-systems in Hawaii and Sweden.
AstaREAL® Targets the THE 10 FACTORS that Kills 1 Boomer Every 2 seconds
AstaREAL® Astaxanthin Reduced Incidences of Stroke up to 50%, Ruptured Plaques in the Arteries up to 49%, and Blood Pressure up to 17%, according to recent studies in USA-Japan
Click her for our newsletterAstaREAL® Receives 2009 Frost & Sullivan Product Innovation Award
Toyama, 4 Feb 2010 – Fuji Chemical Industry Co., Ltd. (Fuji), the Japanese pharmaceutical manufacturing company, announced that it has been recently selected by Frost & Sullivan as the recipient of the 2009 Asia Pacific Product Innovation Award for AstaREAL® in the category of Ingredients for Dietary Supplements.
Frost & Sullivan selected Fuji for its efforts in the research and development of AstaREAL®, the highly potent carotenoid antioxidant called astaxanthin. AstaREAL® astaxanthin has been proven by Fuji to offer a number of health benefits including eye fatigue, muscle endurance and skin health which can be used in the development of dietary supplements. Mr Mitsunori Nishida, President and CEO of Fuji Chemical Industry Ltd., speaks on the development of AstaREAL® worldwide, "It has taken us 15 years of intensive research, process development, and market development to become the most vertically integrated supplier of natural astaxanthin made from the microalgae called Haematococcus pluvialis. This was possible through the collaborative efforts of Japanese, Swedish and American scientists within the Fuji group. The award certainly lifts the group's morale and highlights Fuji's long term commitment for AstaREAL®. The Asia Pacific is an important region for us, so leveraging the industrial recognition will help us a lot in adding brand value for current and new customers."
AstaREAL® astaxanthin, available in both oil and powdered forms has been developed for use in dietary supplements. There is strong evidence from a number of clinically proven studies and human clinical trials to support the fact that the antioxidant profile of AstaREAL® astaxanthin is exceptional when compared to the other common antioxidant products available.
Frost & Sullivan Industry Analyst Ms Archana Jayarajah points out, "Notably, the firm's AstaREAL® astaxanthin is cultivated in ultra-clean BioDomeTM system in Maui, Hawaii and state-of-the-art photobioreactors in Gustavsberg, Sweden. AstaREAL®'s safety and efficacy is supported by a set of comprehensive studies conducted on both animal models and humans to explicitly suggest the lack of any toxicological finding that renders the product safe and effective to use."
Foreseeing the challenges ahead such as tougher market and regulatory requirements, Fuji's pharmaceutical background proves useful. The company has an efficient information network in place amongst the Research and Development, Marketing, Manufacturing, and Quality Control units which has enabled them to work on the needs and requirements of their customers as well as regulatory needs. Their other goal focuses on increasing global awareness and acceptance of AstaREAL® astaxanthin health benefits through evidence backed communication.
About Fuji Chemical Industry Co., Ltd.
Established in the year 1946, Fuji Chemical industry Co. Ltd is headquartered in Kamiichi, Toyama, Japan. The company started out as a bread-yeast maker and grew into a pharmaceutical manufacturer of high performance raw materials and quality custom manufacturing services. In 1994, Fuji commercially entered the nutraceutical market. AstaREAL® astaxanthin is a carotenoid antioxidant for use in dietary supplements and cosmetics. Fuji is committed to producing unique value added products that contribute to the health of societies all over the world, please visit www.fujichemical.co.jp.
Best Practice Award Research Methodology
The award is given each year to the company which has demonstrated leadership in its industry. To choose the award recipient, the analyst team tracks vertical market trends. This is followed by collecting data, based on predetermined measurement criteria, from all the market participants through interviews and extensive secondary research. The collected data is analyzed, and rankings are ascertained from data results. Frost & Sullivan then presents the Award to the company that received the highest industry rank. Please visit www.awards.frost.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit www.frost.com
Contact
Marketing Section, International Business Department
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Tel: +81-(0)3-3437-2353
Three month clinical study shows promise of cardiovascular benefits with natural astaxanthin.
Astaxanthin has been reported to improve dyslipidemia and metabolic syndrome in animals but the effect in humans have not been well studied. A recently published study by Yoshida et al., (2009) is the first long-term investigation in humans to show a positive outcome in subjects with moderately raised level of triglyceride. This suggests cardiovascular health benefits with the intake of natural astaxanthin. The collaborative study was performed in Japan among various medical departments of Jikei University Hospital, Chiba and Fuji Chemical Industry Co., Ltd., Toyama.
Page 1 of 4